221 related articles for article (PubMed ID: 29378343)
1. Anti-Yo-Associated Paraneoplastic Cerebellar Degeneration Manifesting as Acute Cerebellitis with Posterior Cranial Fossa Hypertension.
Enríquez-Marulanda A; Beltrán-Osorio LD; Escobar LA; Granados AM; Velásquez-Lasprilla F; Orozco JL
World Neurosurg; 2018 Apr; 112():117-122. PubMed ID: 29378343
[TBL] [Abstract][Full Text] [Related]
2. Anti-Yo mediated paraneoplastic cerebellar degeneration in the context of breast cancer: a case report and literature review.
Key RG; Root JC
Psychooncology; 2013 Sep; 22(9):2152-5. PubMed ID: 23585287
[TBL] [Abstract][Full Text] [Related]
3. Anti-Yo antibody-mediated paraneoplastic cerebellar degeneration in a female patient with pleural malignant mesothelioma.
Tanriverdi O; Meydan N; Barutca S; Ozsan N; Gurel D; Veral A
Jpn J Clin Oncol; 2013 May; 43(5):563-8. PubMed ID: 23475537
[TBL] [Abstract][Full Text] [Related]
4. Paraneoplastic cerebellar degeneration as the first evidence of malignancy: a case report.
Kumari VA; Gupta P; Srivastava MV; Kumar L; Kriplani A; Bhatla N
J Obstet Gynaecol Res; 2014 May; 40(5):1463-5. PubMed ID: 24689522
[TBL] [Abstract][Full Text] [Related]
5. Anti-Yo antibody-mediated paraneoplastic cerebellar degeneration associated with cognitive affective syndrome in a patient with breast cancer: a case report and literature review.
Le May M; Dent S
Curr Oncol; 2018 Dec; 25(6):e585-e591. PubMed ID: 30607127
[TBL] [Abstract][Full Text] [Related]
6. Paraneoplastic cerebellar degeneration associated with antineuronal antibodies: analysis of 50 patients.
Shams'ili S; Grefkens J; de Leeuw B; van den Bent M; Hooijkaas H; van der Holt B; Vecht C; Sillevis Smitt P
Brain; 2003 Jun; 126(Pt 6):1409-18. PubMed ID: 12764061
[TBL] [Abstract][Full Text] [Related]
7. Anti-Yo positive paraneoplastic cerebellar degeneration in the setting of cholangiocarcinoma.
Bruhnding A; Notch D; Beard A
J Clin Neurosci; 2017 Feb; 36():71-72. PubMed ID: 27816258
[TBL] [Abstract][Full Text] [Related]
8. Paraneoplastic cerebellar degeneration with anti-Yo antibodies associated with metastatic uveal melanoma.
Valpione S; Zoccarato M; Parrozzani R; Pigozzo J; Giometto B; Laveder F; Aliberti C; Chiarion-Sileni V
J Neurol Sci; 2013 Dec; 335(1-2):210-2. PubMed ID: 24035275
[TBL] [Abstract][Full Text] [Related]
9. Paraneoplastic neurological syndrome: patient with anti-Yo antibody and breast cancer: a case report.
Dorn C; Knobloch C; Kupka M; Morakkabati-Spitz N; Schmolling J
Arch Gynecol Obstet; 2003 Nov; 269(1):62-5. PubMed ID: 14605824
[TBL] [Abstract][Full Text] [Related]
10. Paraneoplastic cerebellar degeneration in a patient with pseudomyxoma peritonei and breast cancer: case report and literature review.
Ardavanis A; Sykoutri D; Kountourakis P; Doufexis D; Korkolis D; Tzerbini H; Skarlatos I; Mosa E; Rigatos G
In Vivo; 2009; 23(5):835-8. PubMed ID: 19779120
[TBL] [Abstract][Full Text] [Related]
11. [A case of slowly progressive anti-Yo-associated paraneoplastic cerebellar degeneration successfully treated with antitumor and immunotherapy].
Tsuboguchi S; Yajima R; Higuchi Y; Ishikawa M; Kawachi I; Koyama Y; Nishizawa M
Rinsho Shinkeigaku; 2016 Jul; 56(7):477-80. PubMed ID: 27356731
[TBL] [Abstract][Full Text] [Related]
12. Anti-Yo positive and late-onset paraneoplastic cerebellar degeneration associated with ovarian carcinoma: A case report.
Cui D; Xu L; Li WY; Qian WD
Medicine (Baltimore); 2017 Aug; 96(32):e7362. PubMed ID: 28796031
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis of Dual Malignancy by 18F-FDG PET/CT in the Setting of Paraneoplastic Cerebellar Degeneration.
Thapa P; Basu S
J Nucl Med Technol; 2016 Mar; 44(1):52-3. PubMed ID: 26271804
[TBL] [Abstract][Full Text] [Related]
14. Paraneoplastic cerebellar degeneration with anti-Yo antibodies and an associated submandibular gland tumor: a case report.
Imai T; Shinohara K; Uchino K; Okuma H; Maki F; Hiruma K; Ariizumi Y; Yamano Y
BMC Neurol; 2022 May; 22(1):165. PubMed ID: 35501715
[TBL] [Abstract][Full Text] [Related]
15. Paraneoplastic cerebellar degeneration associated with squamous cell carcinoma of the lung.
Day J; Yan B; Boer RD; Tsui A
J Clin Neurosci; 2013 Oct; 20(10):1448-9. PubMed ID: 23790624
[TBL] [Abstract][Full Text] [Related]
16. Paraneoplastic cerebellar degeneration associated with serous adenocarcinoma of the ovary.
Saeed DB; Gupta L
BMJ Case Rep; 2014 Nov; 2014():. PubMed ID: 25432905
[TBL] [Abstract][Full Text] [Related]
17. Anti-Yo positive paraneoplastic cerebellar degeneration associated with ovarian carcinoma: case report and review of the literature.
Cao Y; Abbas J; Wu X; Dooley J; van Amburg AL
Gynecol Oncol; 1999 Oct; 75(1):178-83. PubMed ID: 10502450
[TBL] [Abstract][Full Text] [Related]
18. Paraneoplastic Cerebellar Degeneration in Nasopharyngeal Carcinoma: a Unique Association.
Bhardwaj S; Khasani S; Benasher D; Stein EG; Meghal T; Jacoby N; Huang YJ
Cerebellum; 2019 Dec; 18(6):1126-1129. PubMed ID: 31161534
[TBL] [Abstract][Full Text] [Related]
19. Human epidermal growth factor receptor 2 overexpression in breast cancer of patients with anti-Yo--associated paraneoplastic cerebellar degeneration.
Rojas-Marcos I; Picard G; Chinchón D; Gelpi E; Psimaras D; Giometto B; Delattre JY; Honnorat J; Graus F
Neuro Oncol; 2012 Apr; 14(4):506-10. PubMed ID: 22351748
[TBL] [Abstract][Full Text] [Related]
20. Transcriptomic immune profiling of ovarian cancers in paraneoplastic cerebellar degeneration associated with anti-Yo antibodies.
Vialatte de Pémille C; Berzero G; Small M; Psimaras D; Giry M; Daniau M; Sanson M; Delattre JY; Honnorat J; Desestret V; Alentorn A
Br J Cancer; 2018 Jul; 119(1):105-113. PubMed ID: 29899393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
